Search PDMR transactions

Notifier
Name
Andrew Udell
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Andrew Udell
Position
VP North America Commercial
Initial notification
Yes
Amendment
No
Details of amendment
Issuer
Name of issuer
Calliditas Therapeutics AB
LEI code
549300PVPZO8TNT76B58
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to a share option programme Volume Unit Price per unit Currency code Transaction date Trading venue
Warrant Warrant program 2019/2022 Acquisition 20,000 Quantity 9.78 SEK 10/07/2019 Outside a trading venue
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Trading venue Volume Weighted average price
Warrant program 2019/2022 Acquisition 10/07/2019 Outside a trading venue 20,000 (Quantity) 9.78 SEK
<< Back